The Pharmacovigilance and Drug Safety Software Market which was valued at USD 6.83 billion in 2022, is projected to grow significantly to USD 14.86 billion by 2030, registering a compound annual growth rate (CAGR) of 10.2% over the forecast period from 2023 to 2030. This robust growth is attributed to the rising importance of monitoring drug safety, increasing...